| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2014 | CN103505472A Spermicide antibacterial anti-infection liquid contraception gel composition and preparation method thereof |
| 01/15/2014 | CN103505471A Dairy cow nipple antifreezing disinfector and preparation method thereof |
| 01/15/2014 | CN103505470A Production method for povidone-iodine solution |
| 01/15/2014 | CN103505469A Special compound levorgyration florfenicol injection for animal and preparation method thereof |
| 01/15/2014 | CN103505468A Application of 3,5,4'-trihydroxy-stilbyl-3'-O-glucoside in preparation of microcirculatory disturbance improvement medicines |
| 01/15/2014 | CN103505467A Applications of stilbene compounds for preparing medicament for preventing and treating depression |
| 01/15/2014 | CN103505466A Solid compound preparation containing metformin hydrochloride and glimepiride, preparation method and application thereof |
| 01/15/2014 | CN103505465A Anti-thrombus medicinal composition containing dabigatran etexilate |
| 01/15/2014 | CN103505464A Application of Phyllanthoid A to preparation of medicine for treating or preventing oral ulcer |
| 01/15/2014 | CN103505463A Blood lipid reducing composition containing linoleic acid and preparation method of composition |
| 01/15/2014 | CN103505462A New uses of 20(S)-protopanaxadiol |
| 01/15/2014 | CN103505461A Solid medicine composition of lercanidipine and benazepril |
| 01/15/2014 | CN103505460A Method for preparing losartan potassium and hydrochlorothiazide composition |
| 01/15/2014 | CN103505459A Pharmaceutical composition of linezolid |
| 01/15/2014 | CN103505458A Application of autophagy inhibitor in preparation of tumor multidrug resistance reversal agent |
| 01/15/2014 | CN103505457A Asplenium nidus extract and use thereof |
| 01/15/2014 | CN103505456A Application of Racemosins A to preparation of medicine for treating or preventing acute heart failure |
| 01/15/2014 | CN103505455A Method for making epileptic seizure animal model |
| 01/15/2014 | CN103505454A Alpha-tubulin inhibitor and application thereof |
| 01/15/2014 | CN103505453A Orlistat oral solid preparation and preparation method thereof |
| 01/15/2014 | CN103505452A Application of epigallocatechingallate in preparing medicines used for inhibiting leucoderma |
| 01/15/2014 | CN103505451A Traditional Chinese medicine composition for treating cardiovascular diseases and preparation method thereof |
| 01/15/2014 | CN103505450A Application of lobaplatin in preparation of drugs used for treating prostate cancer |
| 01/15/2014 | CN103505449A Application of N-acetylcysteine in preparation of drugs for preventing and treating DNA damage and tissue damage induced by synchrotron radiation |
| 01/15/2014 | CN103505448A Method of using rhein for treating fibrotic conditions and tumors |
| 01/15/2014 | CN103505447A Ibuprofen-containing pharmaceutical composition and its use |
| 01/15/2014 | CN103505446A Pharmaceutical composition and its use |
| 01/15/2014 | CN103505445A New application of dimethyldiguanide |
| 01/15/2014 | CN103505444A Application of germacrone in preparation of liver cancer treatment medicines |
| 01/15/2014 | CN103505443A Tamsulosin hydrochloride capsule |
| 01/15/2014 | CN103505442A Target nano lipid core micelle used for carrying docetaxel, and preparation method and applications thereof |
| 01/15/2014 | CN103505441A Oral solid preparation containing biguanides and acarbose and preparation method thereof |
| 01/15/2014 | CN103505440A Stable azelnidipine capsule |
| 01/15/2014 | CN103505439A Mitiglinide calcium capsules |
| 01/15/2014 | CN103505438A Calcium dobesilate capsules |
| 01/15/2014 | CN103505437A Stable pitavastatin calcium capsules |
| 01/15/2014 | CN103505436A Preparation method of lansoprazole capsule |
| 01/15/2014 | CN103505435A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride hard capsule and preparation method thereof |
| 01/15/2014 | CN103505434A Cefuroxime axetil tablet and preparation method thereof |
| 01/15/2014 | CN103505432A Stable mitiglinide calcium tablets |
| 01/15/2014 | CN103505431A Repaglinide tablets |
| 01/15/2014 | CN103505430A Cefixime tablets |
| 01/15/2014 | CN103505429A Gliguidone tablet |
| 01/15/2014 | CN103505428A Glipizide sugar-free tablet |
| 01/15/2014 | CN103505427A Agomelatine tablet |
| 01/15/2014 | CN103505426A Stable azelnidipine tablet |
| 01/15/2014 | CN103505425A Stable pitavastatin calcium tablets |
| 01/15/2014 | CN103505424A Preparation method for bortezomib for injection |
| 01/15/2014 | CN103505423A Bromhexine hydrochloride freeze-dried powder injection and preparation method thereof |
| 01/15/2014 | CN103505422A Solubilized emodin drug-loaded pellet core, colon-targeted pellet and preparation method thereof |
| 01/15/2014 | CN103505421A Duloxetine hydrochloride enteric micropill preparation |
| 01/15/2014 | CN103505420A Liquid crystal nano-preparations as well as preparation method thereof |
| 01/15/2014 | CN103505419A Oxygen-carrying lipidosome with low surface tension and preparation method thereof |
| 01/15/2014 | CN103505418A Medical carrier and medical composition and preparation methods of medical carrier and medical composition |
| 01/15/2014 | CN103505417A 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetoxime hydrochloride aerosol and preparation method thereof |
| 01/15/2014 | CN103505416A Oxygen-carrying fluorocarbon emulsion and preparation method thereof |
| 01/15/2014 | CN103505415A Medium-chain and long-chain fat emulsion injection and preparation method thereof |
| 01/15/2014 | CN103505414A Butylphthalide nasal drop and preparation method thereof |
| 01/15/2014 | CN103505413A Huperzine-A particle long-acting injection and preparation method thereof |
| 01/15/2014 | CN103505412A Method for preparing fluticasone propionate suspension for inhalation |
| 01/15/2014 | CN103505411A Ornidazole injection |
| 01/15/2014 | CN103505410A Single-dosage gatifloxacin eye drop and preparation method thereof |
| 01/15/2014 | CN103505409A 3-n-butylphthalide injection and preparation method thereof |
| 01/15/2014 | CN103505408A Preparation method of oxiracetam glucose/sodium chloride injection |
| 01/15/2014 | CN103505407A Multi-chamber bag packaged moxifloxacin hydrochloride/glucose aqueous solution preparation |
| 01/15/2014 | CN103505406A Nifuratel gel and preparation method thereof |
| 01/15/2014 | CN103505404A Oral liquid preparation with roxithromycin as active component |
| 01/15/2014 | CN103504703A Pure traditional Chinese medicine health-care insole |
| 01/15/2014 | CN103503908A Insecticidal composition containing Paichongding (1-((6-chloropyridine-3-group) methyl-5-propoxy-7-methyl-8-nitryl-1,2,3,5,6,7-hexahydroimidazo[1,2-a] pyridine) and efficient cyhalothrin |
| 01/15/2014 | CN103503907A Insecticidal composition containing 1-((6-chloropyridine-3-yl) methyl)-5-propoxy-7-methyl-8-nitryl-1,2,3,5,6,7-hexahydroimidazo[1,2-alpha] pyridine) and deltamethrin |
| 01/15/2014 | CN103503867A Production method for strong glutaraldehyde solution |
| 01/15/2014 | CN103070841B Mannose ester sustained release tablets and preparation method thereof |
| 01/15/2014 | CN103040804B Norwogonin and application thereof to preparation of medicines for treating acinetobacter baumannii infection |
| 01/15/2014 | CN103007292B MiR-3OB (Micro-Ribonucleic Acid-30b) composite for targeting microglia as well as preparation method and application of composite |
| 01/15/2014 | CN102885785B Adriamycin-containing nanometer medicament microspheres and preparation method thereof |
| 01/15/2014 | CN102885304B BMD (bone mineral density)-increased health food composite and preparation method thereof |
| 01/15/2014 | CN102846872B Traditional Chinese medicine for treating facial paralysis and preparation method thereof |
| 01/15/2014 | CN102836341B Medicinal granule with whitening effect and preparation method thereof |
| 01/15/2014 | CN102824423B Medicinal composition comprising albiflorin and arctiin and application |
| 01/15/2014 | CN102772381B Fasudil-contained pharmaceutical composition |
| 01/15/2014 | CN102755408B External liniment for treating vitiligo |
| 01/15/2014 | CN102743713B Drug rehabilitation traditional Chinese medicine and preparation method thereof |
| 01/15/2014 | CN102732515B Nucleotide sequence and application thereof |
| 01/15/2014 | CN102727546B Health-promoting composition for treating insomnia and cardiovascular/cerebrovascular diseases |
| 01/15/2014 | CN102716465B Pharmaceutical composite for treating tumor and preparation method of pharmaceutical composite |
| 01/15/2014 | CN102716098B Cefditoren pivoxil liposome solid preparation |
| 01/15/2014 | CN102716082B Cefoxitin sodium liposome injection |
| 01/15/2014 | CN102701992B Anti-tumour compound, pharmaceutically accepted salts as well as preparation method and application thereof |
| 01/15/2014 | CN102697720B Irinotecan hydrochloride lipid nanoparticles injection |
| 01/15/2014 | CN102657642B Application of Irosustat in preparing drugs resistant to eimeria tenella |
| 01/15/2014 | CN102626412B Pharmaceutical composition for curing malignant tumor |
| 01/15/2014 | CN102617562B Thiazole derivant and preparation method and use thereof |
| 01/15/2014 | CN102600383B Chinese medicinal herb preparation for poultry and application thereof |
| 01/15/2014 | CN102584916B Lignan triglucoside compound and preparation method and application thereof |
| 01/15/2014 | CN102584914B Glucoside ester compound and preparation method and application thereof |
| 01/15/2014 | CN102579348B Fosinopril sodium liposome solid preparation |
| 01/15/2014 | CN102558535B Amphiphilic block copolymer connected through molecular glue and synthesis method and application of copolymer |
| 01/15/2014 | CN102482290B C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof |
| 01/15/2014 | CN102464659B Licopyrinobuter compound crystal forms, preparation method, and use thereof |
| 01/15/2014 | CN102438626B Novel aminopyridine derivatives having aurora a selective inhibitory action |